Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Inflammatory bowel disease	5/65	7.048319506964223e-09	5.850105190780304e-07	133.46666666666667	-326.78711962344056	IFNG;IL17A;IL1B;IL6;TNF
KEGG_2021_Human	IL-17 signaling pathway	5/94	4.613881700165173e-08	1.2277786559577447e-06	89.65168539325843	-243.34942399375765	IFNG;IL17A;IL1B;IL6;TNF
KEGG_2021_Human	Hematopoietic cell lineage	5/99	5.996272195397143e-08	1.2277786559577447e-06	84.82978723404256	-233.2293906932695	CD4;CD8A;IL1B;IL6;TNF
KEGG_2021_Human	African trypanosomiasis	4/37	7.670863423639076e-08	1.2277786559577447e-06	162.32323232323233	-303.53856217965773	IFNG;IL1B;IL6;TNF
KEGG_2021_Human	Th17 cell differentiation	5/107	8.875508356321046e-08	1.2277786559577447e-06	78.09803921568627	-218.72241114395115	CD4;IFNG;IL17A;IL1B;IL6
KEGG_2021_Human	Rheumatoid arthritis	5/93	4.370736564994153e-08	1.2277786559577447e-06	90.68181818181819	-245.48357760337638	IFNG;IL17A;IL1B;IL6;TNF
KEGG_2021_Human	Graft-versus-host disease	4/42	1.2961519981889268e-07	1.5368659407097276e-06	140.87719298245614	-275.439099811649	IFNG;IL1B;IL6;TNF
KEGG_2021_Human	Malaria	4/50	2.654180841966383e-07	2.7537126235401226e-06	116.26086956521739	-240.55570695978312	IFNG;IL1B;IL6;TNF
KEGG_2021_Human	Yersinia infection	5/137	3.070399768694536e-07	2.831590897796072e-06	60.121212121212125	-177.50304940933535	CD4;CD8A;IL1B;IL6;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	6/295	4.18613825458797e-07	3.474494751308015e-06	40.37543252595156	-139.58751624866832	CD4;IFNG;IL17A;IL1B;IL6;TNF
KEGG_2021_Human	Cytosolic DNA-sensing pathway	4/63	6.811887802918996e-07	5.139878978566151e-06	90.49717514124293	-200.30830604753126	CGAS;IL1B;IL6;STING1
KEGG_2021_Human	Antigen processing and presentation	4/78	1.6166658456855683e-06	1.1181938765991848e-05	72.01801801801801	-168.42130814118732	CD4;CD8A;IFNG;TNF
KEGG_2021_Human	Human cytomegalovirus infection	5/225	3.60640803391693e-06	2.302552821654655e-05	35.67272727272727	-113.77866048874807	CGAS;IL1B;IL6;STING1;TNF
KEGG_2021_Human	Amoebiasis	4/102	4.7476288106462685e-06	2.4628324455227515e-05	54.21768707482993	-134.5540755438832	IFNG;IL1B;IL6;TNF
KEGG_2021_Human	Coronavirus disease	5/232	4.193632481505705e-06	2.4628324455227515e-05	34.541850220264315	-110.54645043588327	CGAS;IL1B;IL6;STING1;TNF
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	2.4628324455227515e-05	54.21768707482993	-134.5540755438832	IFNG;IL1B;IL6;TNF
KEGG_2021_Human	T cell receptor signaling pathway	4/104	5.130876847568527e-06	2.5050751667540455e-05	53.12	-132.3420645012429	CD4;CD8A;IFNG;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	6/498	9.044529937904887e-06	4.1705332491450315e-05	23.097560975609756	-82.2468690367685	CGAS;IFNG;IL1B;IL6;STING1;TNF
KEGG_2021_Human	Type I diabetes mellitus	3/43	1.6429423914376138e-05	7.177064131016945e-05	86.01428571428572	-141.158089869663	IFNG;IL1B;TNF
KEGG_2021_Human	Legionellosis	3/57	3.859950954844004e-05	0.0001525599663105011	63.6031746031746	-112.5302356283168	IL1B;IL6;TNF
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.0001525599663105011	31.349206349206348	-84.54495262531024	IFNG;IL1B;IL6;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	4.608088790455273e-05	0.0001662918998294729	29.721280602636536	-80.60331713278154	IL1B;IL6;STING1;TNF
KEGG_2021_Human	Tuberculosis	4/180	4.508970382755845e-05	0.0001662918998294729	29.893939393939394	-81.02434645013932	IFNG;IL1B;IL6;TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	8.553680416035766e-05	0.0002958147810545703	25.192307692307693	-69.28980198257669	CD4;CGAS;STING1;TNF
KEGG_2021_Human	Pertussis	3/76	9.159620399517935e-05	0.0003040588383750445	46.93737769080235	-88.55605413655218	IL1B;IL6;TNF
KEGG_2021_Human	Leishmaniasis	3/77	9.524734696085732e-05	0.0003040588383750445	46.2972972972973	-87.57744084010389	IFNG;IL1B;TNF
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.00046886077330601046	21.55922865013774	-59.801482853342776	CGAS;IL1B;STING1;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0006148110902422381	35.2179675994109	-69.8003308229761	IL1B;IL6;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	3/104	0.0002329673917108638	0.0006445431170667232	33.806223479490804	-67.40758155759835	IL1B;IL6;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	3/104	0.0002329673917108638	0.0006445431170667232	33.806223479490804	-67.40758155759835	IL1B;IL6;TNF
KEGG_2021_Human	TNF signaling pathway	3/112	0.00029005838446074546	0.0007766079325884476	31.293577981651374	-63.06696788213405	IL1B;IL6;TNF
KEGG_2021_Human	Osteoclast differentiation	3/127	0.0004201187826005964	0.0010896830923702969	27.456221198156683	-56.21805005538481	IFNG;IL1B;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0005476317685268026	0.0013773768723552913	24.99579831932773	-51.672386684351224	IFNG;IL1B;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.0018384940589677508	22.31954887218045	-46.57552582678881	IL1B;IL6;TNF
KEGG_2021_Human	Necroptosis	3/159	0.0008112107732862489	0.0019237284052216759	21.736263736263737	-45.441996978119036	IFNG;IL1B;TNF
KEGG_2021_Human	Allograft rejection	2/38	0.0009469209383415865	0.0021241739968203156	55.77777777777778	-62.87407127134141	IFNG;TNF
KEGG_2021_Human	Primary immunodeficiency	2/38	0.0009469209383415865	0.0021241739968203156	55.77777777777778	-62.87407127134141	CD4;CD8A
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.0032990969868087958	17.394698085419734	-36.72187076283526	IL1B;IL6;TNF
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.004134741543885048	15.881401617250674	-33.55383703082171	IL1B;IL6;TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.004250484680160389	15.579365079365079	-32.91284230349772	CD4;IL6;TNF
KEGG_2021_Human	Salmonella infection	3/249	0.0029568377027043165	0.005985793398157519	13.627177700348431	-28.69609856443984	IL1B;IL6;TNF
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.0031848593502604382	0.0062938887159908665	29.41176470588235	-37.553176952571945	STING1;TNF
KEGG_2021_Human	Prion disease	3/273	0.0038397781028777236	0.007411664710205839	12.377777777777778	-25.926933584065353	IL1B;IL6;TNF
KEGG_2021_Human	Hypertrophic cardiomyopathy	2/90	0.005212350356610659	0.009613890657748548	22.670454545454547	-29.92662218019896	IL6;TNF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.009613890657748548	22.933908045977013	-30.23706529396038	CD4;IFNG
KEGG_2021_Human	Th1 and Th2 cell differentiation	2/92	0.005440715912052039	0.00981694392826781	22.16111111111111	-29.32328202848766	CD4;IFNG
KEGG_2021_Human	TGF-beta signaling pathway	2/94	0.005673660825135872	0.010019443584814412	21.67391304347826	-28.742216935482162	IFNG;TNF
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	2/100	0.006399778215208473	0.011066283163797985	20.331632653061224	-27.120602948412195	IL6;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	2/104	0.006906399428166279	0.011698594949751043	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	Insulin resistance	2/108	0.007430876215757518	0.012311288248391608	18.778301886792452	-25.204052222837845	IL6;TNF
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.012311288248391608	18.600467289719628	-24.98176436194636	IFNG;IL6
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.012726224408155077	18.086363636363636	-24.33571316400054	IFNG;TNF
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.013975406645148354	9.018735362997658	-18.187178129854335	IL1B;IL6;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.016577773973452822	15.385658914728682	-20.853034219946885	IFNG;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.0172437755265134	14.915413533834586	-20.230385574789178	IFNG;TNF
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.017910737620978577	14.472627737226277	-19.639406588988233	IL1B;IL6
KEGG_2021_Human	Cell adhesion molecules	2/148	0.0136245920729854	0.019839318281715583	13.565068493150685	-18.413416454449223	CD4;CD8A
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.021818938108078768	12.762903225806452	-17.312716751580805	IFNG;TNF
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.022386732846219292	12.35625	-16.748364182562245	IL6;TNF
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.022386732846219292	12.35625	-16.748364182562245	IFNG;IL6
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.02418180008368852	6.897094430992736	-13.07371705691191	IL1B;IL6;TNF
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.032844700524465816	9.835	-13.147442958027579	IL6;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.04972164001580745	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.06351962691178842	6.657534246575342	-8.337786615237395	IL1B;TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.06984282086971363	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Proteasome	1/46	0.05553766478796506	0.06984282086971363	19.809876543209878	-11.46289716991079	IFNG
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.07171211877447564	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.09894045075730437	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.09894045075730437	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.13368052184675525	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.13439512070674042	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.156897132870655	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.156897132870655	3.5628544423440456	-3.410136075895621	IFNG;IL6
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.16926391092488732	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.1799401097931918	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.19107328226297202	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.19107328226297202	5.672401433691756	-3.209640069203435	IL6
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2257919399437409	4.5823152995927865	-2.441961042053517	IL6
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.2257919399437409	4.55787037037037	-2.4244944960200487	IL6
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.23528812530152235	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.35049454745739367	2.6053872053872054	-1.0106876845884132	TNF
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.3657414099963155	2.4283915643689014	-0.883914601009246	IL6
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
